No Data
In December, both domestic and imported game licenses were released! A total of 1416 licenses have been issued this year, the highest in the past five years.
① A total of 122 domestic games and 13 imported new games were approved today, marking the third consecutive month of simultaneous issuance of domestic and imported game licenses. Major games from Tencent and NetEase received approvals, along with several other publicly listed game companies also achieving gains. ② As of the time of writing, 1,416 new games have obtained licenses this year, the highest total in nearly five years.
Sensor Tower: In November, 35 Chinese mobile game companies collectively earned 1.87 billion USD, accounting for 34.8% of the income of the Global TOP 100 mobile game publishers.
The Sensor Tower store intelligence platform shows that in November 2024, 35 Chinese companies made it to the Global mobile game publisher revenue ranking TOP 100, collectively earning 1.87 billion dollars, accounting for 34.8% of the total revenue of the Global TOP 100 mobile game publishers this period.
IDreamSky Technology Affiliate to Cooperate With Saudi Gaming Platform
IDREAMSKY has reached a cooperation with the Saudi Game Platform, yet the stock price has dropped over 3%.
① What agreement has IDREAMSKY reached with stc play? ② How has IDREAMSKY's recent performance been?
Hong Kong stock early report on December 19: The hawkish Federal Reserve caused U.S. stocks to fall. IDREAMSKY has reached a cooperation with the Game Platform under Saudi Telecom Company (STC).
① Shenzhen established an AI industry Fund. ② The Federal Reserve lowered interest rates by 25 basis points as expected, with only two rate cuts anticipated in 2025. ③ The Hong Kong Securities and Futures Commission granted licenses to virtual Asset Trade platforms under an expedited licensing process. ④ The USA Biodefense Act was not included in the CR bill.
Hong Kong stock announcement to uncover opportunities | SHOUCHENG intends to sell approximately 0.607 billion shares of SHOUGANG RES for about 1.4566 billion Hong Kong dollars.
IDREAMSKY (01119) has reached a collaboration with stc play in the fields of technology and gaming. ASCLETIS-B (01672): The weight loss candidate drug ASC47, which treats obesity, has shown better weight loss effects than single-agent semaglutide in preclinical models when used in combination.
There's No Escaping IDreamSky Technology Holdings Limited's (HKG:1119) Muted Revenues Despite A 37% Share Price Rise
